Drug Type Oligonucleotide |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD8 inhibitors(Cluster of differentiation 8 inhibitors), ELOVL1 inhibitors(ELOVL fatty acid elongase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | - | 13 Nov 2025 | |
| Neoplasms | Discovery | - | 13 Nov 2025 |





